Overview A Dose Escalation Study of Bradanicline in Refractory Chronic Cough Status: Completed Trial end date: 2019-05-22 Target enrollment: Participant gender: Summary This is a randomized, double-blind, placebo-controlled, crossover, dose escalation study of bradanicline in subjects with chronic cough Phase: Phase 2 Details Lead Sponsor: Attenua, Inc.